Stay updated with breaking news from Molecular Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The goal in highlighting this development is to attempt to raise awareness of the critical issue of information overload and the need for multiple involved parties to actively and aggressively search for appropriate, effective, and fiscally rational solutions.
While there are considerable barriers to incorporating comprehensive genotyping, the use of circulating tumor DNA offers an improvement in molecular testing—and doing so earlier can accelerate the time to treatment and improve survival for patients with lung cancer.
/PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China, announced that it had received a...
/PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China, announced that it had received a...
SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") MKD, a technology-driven platform in China, announced